BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32066626)

  • 1. Targeted Brain Tumor Radiotherapy Using an Auger Emitter.
    Pirovano G; Jannetti SA; Carter LM; Sadique A; Kossatz S; Guru N; Demétrio De Souza França P; Maeda M; Zeglis BM; Lewis JS; Humm JL; Reiner T
    Clin Cancer Res; 2020 Jun; 26(12):2871-2881. PubMed ID: 32066626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer.
    Sreekumar S; Zhou D; Mpoy C; Schenk E; Scott J; Arbeit JM; Xu J; Rogers BE
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer.
    Hoffman SLV; Mixdorf JC; Kwon O; Johnson TR; Makvandi M; Lee H; Aluicio-Sarduy E; Barnhart TE; Jeffery JJ; Patankar MS; Engle JW; Bednarz BP; Ellison PA
    Nucl Med Biol; 2023; 122-123():108368. PubMed ID: 37490805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy.
    Destro G; Chen Z; Chan CY; Fraser C; Dias G; Mosley M; Guibbal F; Gouverneur V; Cornelissen B
    Nucl Med Biol; 2023; 116-117():108312. PubMed ID: 36621256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP-targeted Meitner-Auger Electron-emitting Radiopharmaceutical for Radioligand Therapy.
    Tan KV
    Radiol Imaging Cancer; 2023 Nov; 5(6):e239022. PubMed ID: 37975803
    [No Abstract]   [Full Text] [Related]  

  • 6. Iodine nanoparticle radiotherapy of human breast cancer growing in the brains of athymic mice.
    Hainfeld JF; Ridwan SM; Stanishevskiy FY; Smilowitz HM
    Sci Rep; 2020 Sep; 10(1):15627. PubMed ID: 32973267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes.
    Ambur Sankaranarayanan R; Kossatz S; Weber W; Beheshti M; Morgenroth A; Mottaghy FM
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32640708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical and first-in-human-brain-cancer applications of [
    Young RJ; Demétrio De Souza França P; Pirovano G; Piotrowski AF; Nicklin PJ; Riedl CC; Schwartz J; Bale TA; Donabedian PL; Kossatz S; Burnazi EM; Roberts S; Lyashchenko SK; Miller AM; Moss NS; Fiasconaro M; Zhang Z; Mauguen A; Reiner T; Dunphy MP
    Neurooncol Adv; 2020; 2(1):vdaa119. PubMed ID: 33392502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy.
    Jannetti SA; Zeglis BM; Zalutsky MR; Reiner T
    Front Pharmacol; 2020; 11():170. PubMed ID: 32194409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved radiosynthesis of
    Wilson TC; Jannetti SA; Guru N; Pillarsetty N; Reiner T; Pirovano G
    Int J Radiat Biol; 2023; 99(1):70-76. PubMed ID: 32552309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview.
    Filippi L; Urso L; Evangelista L
    Curr Issues Mol Biol; 2024 Mar; 46(4):3039-3049. PubMed ID: 38666920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Radioligand Theranostics in Oncology.
    Lawal IO; Abubakar SO; Ndlovu H; Mokoala KMG; More SS; Sathekge MM
    Mol Diagn Ther; 2024 May; 28(3):265-289. PubMed ID: 38555542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair.
    Khazaei Monfared Y; Heidari P; Klempner SJ; Mahmood U; Parikh AR; Hong TS; Strickland MR; Esfahani SA
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization.
    Zhang Y; Liang L; Li Z; Huang Y; Jiang M; Zou B; Xu Y
    Front Oncol; 2023; 13():1295579. PubMed ID: 38111536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Chan CY; Chen Z; Guibbal F; Dias G; Destro G; O'Neill E; Veal M; Lau D; Mosley M; Wilson TC; Gouverneur V; Cornelissen B
    J Nucl Med; 2023 Dec; 64(12):1965-1971. PubMed ID: 37770109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical protocol for large-scale copper-mediated radioiodination of organoboronic precursors: Radiosynthesis of [
    Zhou D; Chu W; Xu J
    J Labelled Comp Radiopharm; 2023 Nov; 66(13):435-439. PubMed ID: 37735764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy.
    Bolcaen J; Gizawy MA; Terry SYA; Paulo A; Cornelissen B; Korde A; Engle J; Radchenko V; Howell RW
    J Nucl Med; 2023 Sep; 64(9):1344-1351. PubMed ID: 37591544
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.